OTCMKTS:PHGUF - Pharming Group Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Pharming Group Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $1.50 0.00 (0.00 %) (As of 01/29/2020 12:09 PM ET) Add Compare Today's Range$1.46Now: $1.50▼$1.5450-Day Range$1.50MA: $1.70▼$1.8152-Week Range$0.79Now: $1.50▼$1.82Volume8,057 shsAverage Volume5,158 shsMarket Capitalization$868.53 millionP/E RatioN/ADividend YieldN/ABeta1.31 ProfileAnalyst RatingsAdvanced ChartEarningsHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Pharming Group N.V., a specialty pharmaceutical company, develops and produces human therapeutic proteins for the treatment of rare diseases and unmet medical needs. The company's lead product is Ruconest, a recombinant human C1 esterase inhibitor that is used for the treatment of angioedema attacks in patients with acute hereditary angioedema (HAE) in Europe, the United States, Israel, European Union countries, Norway, Iceland, and Liechtenstein. Read More… Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Tobacco products Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:PHGUF Previous SymbolOTC:PHGUF CUSIPN/A CIKN/A Webhttp://www.pharming.com/ Phone31-71-524-7400Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$101.24 million Price / Sales8.58 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees183 Outstanding Shares579,020,000Market Cap$868.53 million Next Earnings DateN/A OptionableNot Optionable Receive PHGUF News and Ratings via Email Sign-up to receive the latest news and ratings for PHGUF and its competitors with MarketBeat's FREE daily newsletter. OTC:PHGUF Rates by TradingView Pharming Group (OTCMKTS:PHGUF) Frequently Asked Questions What is Pharming Group's stock symbol? Pharming Group trades on the OTCMKTS under the ticker symbol "PHGUF." How were Pharming Group's earnings last quarter? Pharming Group (OTCMKTS:PHGUF) posted its quarterly earnings data on Thursday, March, 5th. The biotechnology company reported $0.05 EPS for the quarter, beating the consensus estimate of $0.04 by $0.01. View Pharming Group's Earnings History. Has Pharming Group been receiving favorable news coverage? Media stories about PHGUF stock have trended very negative on Wednesday, according to InfoTrie. The research group rates the sentiment of press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Pharming Group earned a media sentiment score of -3.3 on InfoTrie's scale. They also assigned news stories about the biotechnology company a news buzz of 2.0 out of 10, meaning that recent press coverage is very unlikely to have an impact on the stock's share price in the near term. View News Stories for Pharming Group. Who are some of Pharming Group's key competitors? Some companies that are related to Pharming Group include Turning Point Brands (TPB), Standard Diversified Inc Class A (NYSEAMERICAN) (SDI), ADOCIA/S (ADOCY), Healthier Choices Management (HCMC) and Gilla (GLLA). What other stocks do shareholders of Pharming Group own? Based on aggregate information from My MarketBeat watchlists, some companies that other Pharming Group investors own include GALAPAGOS NV/S (GLPG), ArcelorMittal (MT), Net Element (NETE), Pieris Pharmaceuticals (PIRS), Bausch Health Companies (BHC), BIOLINERX LTD/S (BLRX), TIGENIX/S (TIG), Brainstorm Cell Therapeutics (BCLI), Cellectis (CLLS) and Accsys Technologies (AXS). Who are Pharming Group's key executives? Pharming Group's management team includes the folowing people: Dr. Sijmen de Vries M.D., MBA, Chairman of Management Board & CEO (Age 60)Mr. Robin Wright BA (Oxon), FCA., CFO & Member of Management Board (Age 55)Dr. Bruno M. L Giannetti, COO & Member of Management Board (Age 67)Dr. Pericles Calias, Chief Scientific Officer (Age 51)Ms. Anne-Marie de Groot, Sr. VP of Organisational Devel. (Age 38) How do I buy shares of Pharming Group? Shares of PHGUF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab. What is Pharming Group's stock price today? One share of PHGUF stock can currently be purchased for approximately $1.50. How big of a company is Pharming Group? Pharming Group has a market capitalization of $868.53 million and generates $101.24 million in revenue each year. Pharming Group employs 183 workers across the globe.View Additional Information About Pharming Group. What is Pharming Group's official website? The official website for Pharming Group is http://www.pharming.com/. How can I contact Pharming Group? Pharming Group's mailing address is Darwinweg 24, Leiden P7, 2333 CR. The biotechnology company can be reached via phone at 31-71-524-7400 or via email at [email protected] MarketBeat Community Rating for Pharming Group (OTCMKTS PHGUF)Community Ranking: 2.2 out of 5 ( )Outperform Votes: 156 (Vote Outperform)Underperform Votes: 196 (Vote Underperform)Total Votes: 352MarketBeat's community ratings are surveys of what our community members think about Pharming Group and other stocks. Vote "Outperform" if you believe PHGUF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PHGUF will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 1/29/2020 by MarketBeat.com StaffFeatured Article: What member countries make up the G-20?
